Dr Richard Hopkins 

​Chief Executive Officer

Dr Hopkins is an experienced pharmaceutical executive with over 10 years in corporate leadership roles.

Dr Richard Mollard 

​Chief Scientific Officer

Dr Mollard has over 20 years of international experience in academia and biotech/pharma companies.

Dr Wayne Best 


Wayne has almost 30 years’ experience in synthetic and medicinal chemistry both in academia, government and industry

Mr Robert Bishop 

​Executive Director

Robert has 30 years’ experience in corporate finance and equity​.

Dr Roger Aston  

Executive Chairman

Previously at Wellcome Research Laboratories, Peptech and Cambridge Antibody Technology.
Also QinetiQ, pSivida, Clinuvel, HalcyGen and Ascent Pharma Health. More recently CEO of Mayne Pharma Group.

Mr Sam Wright 
Finance Director
Mr Wright has over 15 years experience in the pharmaceutical, biotech and healthcare industry.

The principal activities of the company are to develop its own drug discovery intellectual property, namely three platforms for the treatment of different types of cancers in humans and animals, as well as providing highly specialised medicinal and synthetic chemistry services on a contract basis to clients.

Principal Activities

Our Directors & Senior Management